Active Idiotypic Vaccination Versus Control Immunotherapy for Follicular Lymphoma

PURPOSE: Idiotypes (Ids), the unique portions of tumor immunoglobulins, can serve as targets for passive and active immunotherapies for lymphoma. We performed a multicenter, randomized trial comparing a specific vaccine (MyVax), comprising Id chemically coupled to keyhole limpet hemocyanin (KLH) plu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Levy, Ronald, Ganjoo, Kristen N., Leonard, John P., Vose, Julie M., Flinn, Ian W., Ambinder, Richard F., Connors, Joseph M., Berinstein, Neil L., Belch, Andrew R., Bartlett, Nancy L., Nichols, Craig, Emmanouilides, Christos E., Timmerman, John M., Gregory, Stephanie A., Link, Brian K., Inwards, David J., Freedman, Arnold S., Matous, Jeffrey V., Robertson, Michael J., Kunkel, Lori A., Ingolia, Diane E., Gentles, Andrew J., Liu, Chih Long, Tibshirani, Robert, Alizadeh, Ash A., Denney, Dan W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2014
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4039868/
https://ncbi.nlm.nih.gov/pubmed/24799467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.43.9273
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados